Neuberger Berman Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $269M | Buy |
1,234,836
+51,940
| +4% | +$11.5M | 0.2% | 97 |
|
|
2025
Q4 | $270M | Sell |
1,182,896
-5,060
| -0.4% | -$1.15M | 0.2% | 102 |
|
|
2025
Q3 | $275M | Sell |
1,187,956
-52,298
| -4% | -$10.6M | 0.2% | 99 |
|
|
2025
Q2 | $230M | Sell |
1,240,254
-132,804
| -10% | -$24.7M | 0.18% | 129 |
|
|
2025
Q1 | $288M | Sell |
1,373,058
-111,196
| -7% | -$21.6M | 0.24% | 92 |
|
|
2024
Q4 | $264M | Sell |
1,484,254
-737,973
| -33% | -$136M | 0.21% | 113 |
|
|
2024
Q3 | $439M | Buy |
2,222,227
+268,852
| +14% | +$50.2M | 0.34% | 57 |
|
|
2024
Q2 | $335M | Buy |
1,953,375
+99,497
| +5% | +$16.5M | 0.28% | 84 |
|
|
2024
Q1 | $338M | Buy |
1,853,878
+271,927
| +17% | +$46.9M | 0.28% | 78 |
|
|
2023
Q4 | $245M | Buy |
1,581,951
+13,791
| +0.9% | +$2.01M | 0.21% | 122 |
|
|
2023
Q3 | $234M | Sell |
1,568,160
-27,778
| -2% | -$4.08M | 0.21% | 123 |
|
|
2023
Q2 | $215M | Sell |
1,595,938
-169,599
| -10% | -$24.9M | 0.19% | 137 |
|
|
2023
Q1 | $281M | Buy |
1,765,537
+192,280
| +12% | +$29.4M | 0.26% | 103 |
|
|
2022
Q4 | $254M | Buy |
1,573,257
+538,677
| +52% | +$82.6M | 0.25% | 107 |
|
|
2022
Q3 | $139M | Sell |
1,034,580
-156,026
| -13% | -$22.4M | 0.15% | 200 |
|
|
2022
Q2 | $183M | Buy |
1,190,606
+54,935
| +5% | +$8.39M | 0.18% | 159 |
|
|
2022
Q1 | $184M | Buy |
1,135,671
+13,831
| +1% | +$2.01M | 0.16% | 190 |
|
|
2021
Q4 | $146M | Buy |
1,121,840
+148,914
| +15% | +$17.6M | 0.11% | 253 |
|
|
2021
Q3 | $101M | Sell |
972,926
-532,681
| -35% | -$60.9M | 0.09% | 303 |
|
|
2021
Q2 | $166M | Buy |
1,505,607
+449,737
| +43% | +$50.7M | 0.14% | 219 |
|
|
2021
Q1 | $114M | Buy |
1,055,870
+420,875
| +66% | +$45M | 0.11% | 270 |
|
|
2020
Q4 | $67.8M | Sell |
634,995
-225,282
| -26% | -$21.6M | 0.07% | 342 |
|
|
2020
Q3 | $75.2M | Sell |
860,277
-63,605
| -7% | -$5.99M | 0.09% | 289 |
|
|
2020
Q2 | $90.6M | Buy |
923,882
+382,265
| +71% | +$33.7M | 0.11% | 251 |
|
|
2020
Q1 | $41.3M | Buy |
541,617
+77,925
| +17% | +$6.64M | 0.06% | 360 |
|
|
2019
Q4 | $41.1M | Buy |
463,692
+9,239
| +2% | +$767K | 0.05% | 438 |
|
|
2019
Q3 | $34.4M | Sell |
454,453
-25,325
| -5% | -$1.74M | 0.04% | 457 |
|
|
2019
Q2 | $34.9M | Sell |
479,778
-2,510
| -0.5% | -$197K | 0.04% | 468 |
|
|
2019
Q1 | $38.9M | Sell |
482,288
-56,083
| -10% | -$4.59M | 0.05% | 440 |
|
|
2018
Q4 | $49.6M | Sell |
538,371
-38,542
| -7% | -$3.39M | 0.07% | 360 |
|
|
2018
Q3 | $54.6M | Sell |
576,913
-20,933
| -4% | -$1.99M | 0.06% | 388 |
|
|
2018
Q2 | $55.5M | Sell |
597,846
-4,322
| -0.7% | -$422K | 0.06% | 390 |
|
|
2018
Q1 | $57.1M | Sell |
602,168
-138,433
| -19% | -$15.2M | 0.07% | 378 |
|
|
2017
Q4 | $71.7M | Buy |
740,601
+128,013
| +21% | +$12.1M | 0.08% | 333 |
|
|
2017
Q3 | $54.4M | Buy |
612,588
+14,176
| +2% | +$1.08M | 0.07% | 378 |
|
|
2017
Q2 | $43.4M | Buy |
598,412
+3,546
| +0.6% | +$238K | 0.06% | 415 |
|
|
2017
Q1 | $38.8M | Buy |
594,866
+3,907
| +0.7% | +$246K | 0.05% | 437 |
|
|
2016
Q4 | $37M | Sell |
590,959
-17,884
| -3% | -$1.09M | 0.05% | 438 |
|
|
2016
Q3 | $38.4M | Sell |
608,843
-39,779
| -6% | -$2.58M | 0.05% | 438 |
|
|
2016
Q2 | $40.2M | Sell |
648,622
-57,282
| -8% | -$3.49M | 0.06% | 416 |
|
|
2016
Q1 | $40.3M | Buy |
705,904
+40,790
| +6% | +$2.27M | 0.06% | 418 |
|
|
2015
Q4 | $39.4M | Sell |
665,114
-73,667
| -10% | -$4.24M | 0.05% | 433 |
|
|
2015
Q3 | $40.2M | Buy |
738,781
+83,584
| +13% | +$5.44M | 0.05% | 432 |
|
|
2015
Q2 | $44M | Sell |
655,197
-39,678
| -6% | -$2.59M | 0.05% | 459 |
|
|
2015
Q1 | $40.7M | Sell |
694,875
-14,346
| -2% | -$867K | 0.04% | 478 |
|
|
2014
Q4 | $46.4M | Sell |
709,221
-163,005
| -19% | -$10.3M | 0.05% | 438 |
|
|
2014
Q3 | $50.4M | Sell |
872,226
-515,941
| -37% | -$28.6M | 0.05% | 426 |
|
|
2014
Q2 | $78.3M | Sell |
1,388,167
-502,944
| -27% | -$26.4M | 0.08% | 347 |
|
|
2014
Q1 | $97.2M | Sell |
1,891,111
-2,486,305
| -57% | -$126M | 0.1% | 302 |
|
|
2013
Q4 | $231M | Sell |
4,377,416
-691,235
| -14% | -$34M | 0.24% | 116 |
|
|
2013
Q3 | $227M | Sell |
5,068,651
-73,263
| -1% | -$3.25M | 0.25% | 112 |
|
|
2013
Q2 | $213M | Buy |
+5,141,914
| New | +$225M | 0.25% | 111 |
|
Other funds holding ABBV
VCM
VPM
Neuberger Berman Group's ABBV Position: Q1 2026 in Review
Neuberger Berman Group increased its AbbVie (ABBV) stake by 4.4% in Q1 2026, buying an estimated $11.5M and bringing the position to 1,234,836 shares worth $269M. The position accounts for 0.2% of the portfolio, ranked #97.
Neuberger Berman Group first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $439M in Q3 2024. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Neuberger Berman Group held 1,234,836 shares of AbbVie worth $269M as of Q1 2026.
- Neuberger Berman Group bought 51,940 AbbVie shares in Q1 2026, an estimated $11.5M.
- AbbVie made up 0.2% of Neuberger Berman Group's portfolio in Q1 2026, its #97 holding.
- Neuberger Berman Group first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Neuberger Berman Group's AbbVie position peaked at $439M in Q3 2024.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.